WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world’s leading pharmaceutical and biotechnology companies, today announced that its Board of Directors has set October 5, 2007 as the date for its 2007 Annual Meeting of Stockholders (the “Meeting”) for stockholders of record as of August 28, 2007.
